Jennifer F. Tseng

机构：City of Hope, HOPE Clinic · ORCID：0000-0002-9124-8153

发表论文 249 篇 · 总被引 6704 次 · h-index 43

代表论文

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial (2024 · Nature Medicine · 被引 46)
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer (2023 · Breast Cancer Research and Treatment · 被引 18)
Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial (2024 · Nature Medicine · 被引 13)
Rates of pathologic complete response (pCR) after datopotamab deruxtecan (Dato) plus durvalumab (Durva) in the neoadjuvant setting: Results from the I-SPY2.2 trial. (2024 · Journal of Clinical Oncology · 被引 13)
Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative (2024 · Journal of Surgical Oncology · 被引 8)
Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative (2022 · Journal of Surgical Oncology · 被引 6)